Q/C Technologies, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Q/C Technologies, Inc. (QCLS) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $808.66 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-12
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $808.66K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $867.83K.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.18M.
- 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $703.77K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $808.66K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $867.83K 10-Q · filed 2026-05-15 |
| 2023-06-30 | $3.18M 10-Q · filed 2023-08-14 |
| 2022-06-30 | $703.77K 10-Q · filed 2023-08-14 |
| 2018-06-30 | $1.48K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $4.22K 10-Q · filed 2018-07-13 |
| 2017-12-31 | $6.93K 10-K/A · filed 2018-07-13 |
| 2017-09-30 | $9.70K 10-Q/A · filed 2018-07-13 |
| 2017-06-30 | $23.17K 10-Q/A · filed 2018-07-13 |
| 2017-03-31 | $28.26K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $33.30K 10-K · filed 2017-04-11 |
| 2016-09-30 | $38.44K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $33.30K 10-K · filed 2017-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |